NCT07769125

Brief Summary

This prospective observational cohort study evaluated the relationship between peri-implant soft tissue characteristics and early marginal bone loss following dental implant placement. The study included patients receiving bone-level implants in posterior edentulous regions. Keratinized mucosa width, supracrestal tissue height, and mucosal thickness were measured at the time of implant placement. Marginal bone levels were assessed using standardized intraoral radiographs obtained at baseline and three months after implant placement. The primary aim was to determine whether these peri-implant soft tissue dimensions were associated with marginal bone loss during the early healing period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 8, 2023

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2026

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

August 12, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 17, 2026

Completed
Last Updated

August 17, 2026

Status Verified

August 1, 2026

Enrollment Period

2.4 years

First QC Date

August 12, 2026

Last Update Submit

August 12, 2026

Conditions

Keywords

dental implantsperi-implant soft tissueperi-implant phenotypemarginal bone losskeratinized mucosasupracrestal tissue heightmucosal thickness

Outcome Measures

Primary Outcomes (1)

  • Marginal Bone Loss Around Dental Implants

    Marginal bone loss was determined from standardized intraoral periapical radiographs obtained at implant placement (baseline) and at the three-month follow-up. Marginal bone level was measured on the mesial and distal aspects of each implant as the distance from the implant platform to the first bone-to-implant contact. Measurements were calibrated using the known implant length. Marginal bone loss was calculated as the change in marginal bone level from baseline to three months, and the mean of the mesial and distal measurements was used for analysis. Higher values indicate greater marginal bone loss.

    Baseline to 3 months after implant placement

Study Arms (1)

Patients Receiving Dental Implants

A single prospective cohort of patients receiving bone-level dental implants in posterior edentulous regions. Peri-implant soft tissue dimensions, including keratinized mucosa width, supracrestal tissue height, and mucosal thickness, were measured at implant placement. Participants were not assigned to groups based on these measurements; soft tissue dimensions were evaluated as observational exposure variables in relation to marginal bone changes during the three-month follow-up.

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patients presenting to the Department of Periodontology, Faculty of Dentistry, Ankara University, for implant-supported rehabilitation of posterior edentulous regions were considered for participation in this prospective cohort study. Eligible patients who underwent bone-level dental implant placement and agreed to participate were prospectively enrolled.

You may qualify if:

  • Age between 20 and 60 years. Good general health. Need for dental implant treatment in a posterior edentulous region. Adequate native bone volume for implant placement without bone augmentation. At least 3 months since tooth extraction at the planned implant site. Presence of stable opposing teeth. Adequate oral hygiene. Ability to attend follow-up visits

You may not qualify if:

  • Heavy smoking. Uncontrolled systemic disease. Pregnancy. Use of antibiotics or anti-inflammatory medications within the previous 3 months.
  • Bruxism. Poor oral hygiene. Need for bone augmentation at the implant site.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara University Faculty of Dentistry

Ankara, Ankara, 06560, Turkey (Türkiye)

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asst Prof Dr

Study Record Dates

First Submitted

August 12, 2026

First Posted

August 17, 2026

Study Start

August 8, 2023

Primary Completion

January 15, 2026

Study Completion

January 15, 2026

Last Updated

August 17, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be publicly shared due to participant confidentiality and data protection considerations. Aggregated study findings will be reported in scientific publications.

Locations